Got to remember EU market is 1 billion growing 3% annual, hit this one out of the park then we can focus on FDA. How many times have Companies approached it this way, countless.
big derisk now as we know what to expect. Big re-rate for company coming when market catches on that we are at 17 mill EV for a company starting PHASE 3 trials
